Impairments and Other Charges |
6 Months Ended | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | ||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||
Impairments and Other Charges | Impairments and Other Charges The following table presents various pre-tax charges we recorded during the six months ended June 30, 2025, which are reflected within “Impairments and other charges” on our condensed consolidated statements of operations.
to our Completion and Production segment, $85 million was attributable to our Drilling and Evaluation segment, and $70 million was attributable to Corporate and other. During the six months ended June 30, 2025, we recorded $107 million in severance expense as we rationalized global headcount to align with activity levels and $104 million of additional impairment charges associated with a strategic decision to market for sale a portion of our chemical business. Additionally, we recognized a $53 million impairment related to facility closures and lease terminations. Other charges of $92 million is primarily related to legacy environmental remediation cost estimate increases.
|